NCT05680870 2025-09-09
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Tanta University
Phase 3 Completed
Clinical Trials
8 trialsNCT00339768 2019-12-12
A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT04154748 2019-11-19
Argon Plasma Coagulation for Barrett's Esophagus
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Completed
NCT01566474 2019-09-13
Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study
Aragon Institute of Health Sciences
Phase 3 Completed
NCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed
NCT01465113 2016-03-10
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02518373 2015-08-07
CC5
Cancer Advances Inc.
Phase 2 Completed
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed